The conference will focus on advances in the formulation and development of inhaled medicines. This is a sector in strong and continuous evolution, with growing attention towards the introduction of innovative medicines intended for local or systemic treatment. The topics covered by the sessions will be related to inhalation of biologics such as DNA/RNA-based therapies, new therapies for unmet diseases (cough, cancer, lung infection, idiopathic pulmonary fibrosis), MDI propellant transition and nasal drug delivery.
A scientific session will be dedicated to young researchers and the promotion of their research.
The meeting will be an opportunity to showcase and share research achievements and to interact with leading researchers and companies in this field.
Speakers of high international reputation on the development of inhalation products have already confirmed their participation.
SCIENTIFIC COMMITEE
Conference Chair
Prof. Francesca Buttini
University of Parma
Prof. Carsten Ehrhardt
Trinity College Dublin
Prof. Ben
Forbes
King’s College
London
Prof. Regina Scherließ
Kiel
University
Prof. Fabio Sonvico
University of Parma
Prof. Daniela Traini
Macquarie Medical School
With unconditional support from
PLATINUM SPONSORS
GOLD SPONSORS
SILVER SPONSORS
BRONZE SPONSORS
Under the patronage of
